418 related articles for article (PubMed ID: 19066512)
1. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
2. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans.
Cao S; Gelwix CC; Caldwell KA; Caldwell GA
J Neurosci; 2005 Apr; 25(15):3801-12. PubMed ID: 15829632
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
Lee SH; Han YT; Cha DS
Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
[TBL] [Abstract][Full Text] [Related]
4. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA
Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237
[TBL] [Abstract][Full Text] [Related]
6. Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease.
Harrington AJ; Knight AL; Caldwell GA; Caldwell KA
Methods; 2011 Mar; 53(3):220-5. PubMed ID: 21195766
[TBL] [Abstract][Full Text] [Related]
7. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
[TBL] [Abstract][Full Text] [Related]
8. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
9. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
[TBL] [Abstract][Full Text] [Related]
10. Infections of
Kitisin T; Muangkaew W; Sukphopetch P
Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
[TBL] [Abstract][Full Text] [Related]
11. Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans.
Kuwahara T; Koyama A; Gengyo-Ando K; Masuda M; Kowa H; Tsunoda M; Mitani S; Iwatsubo T
J Biol Chem; 2006 Jan; 281(1):334-40. PubMed ID: 16260788
[TBL] [Abstract][Full Text] [Related]
12. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
[TBL] [Abstract][Full Text] [Related]
14. Modeling dopamine neuron degeneration in Caenorhabditis elegans.
Tucci ML; Harrington AJ; Caldwell GA; Caldwell KA
Methods Mol Biol; 2011; 793():129-48. PubMed ID: 21913098
[TBL] [Abstract][Full Text] [Related]
15. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
16. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
[TBL] [Abstract][Full Text] [Related]
17. 2-Butoxytetrahydrofuran, Isolated from
Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
[TBL] [Abstract][Full Text] [Related]
18. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
Yao C; El Khoury R; Wang W; Byrd TA; Pehek EA; Thacker C; Zhu X; Smith MA; Wilson-Delfosse AL; Chen SG
Neurobiol Dis; 2010 Oct; 40(1):73-81. PubMed ID: 20382224
[TBL] [Abstract][Full Text] [Related]
19. Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.
Du G; Liu X; Chen X; Song M; Yan Y; Jiao R; Wang CC
Mol Biol Cell; 2010 Jul; 21(13):2128-37. PubMed ID: 20444973
[TBL] [Abstract][Full Text] [Related]
20. Modeling Parkinson's Disease in C. elegans.
Cooper JF; Van Raamsdonk JM
J Parkinsons Dis; 2018; 8(1):17-32. PubMed ID: 29480229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
